ethinyl estradiol has been researched along with Weight Loss in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersen, M; Christensen, MMH; Glintborg, D; Pedersen, AJT; Stage, TB | 1 |
| Mayeda, ER; Torgal, AH; Westhoff, CL | 1 |
| Alacacioglu, A; Kebapcilar, AG; Kebapcilar, L; Sari, I; Taner, CE | 1 |
| Akpek, M; Calapkorur, B; Celik, A; Karaca, Z; Kaya, MG; Kelestimur, F; Unluhizarci, K; Yildirim, S | 1 |
| Arner, P; Bergqvist, A; Carlström, K; Ek, I; Reynisdottir, S; Wahrenberg, H | 1 |
| Letterie, GS | 1 |
4 trial(s) available for ethinyl estradiol and Weight Loss
| Article | Year |
|---|---|
The Pharmacogenetics of Metformin in Women with Polycystic Ovary Syndrome: A Randomized Trial.
Topics: Adult; Ataxia Telangiectasia Mutated Proteins; Biomarkers; Blood Glucose; Contraceptives, Oral, Hormonal; Desogestrel; Drug Therapy, Combination; Ethinyl Estradiol; Female; Hepatocyte Nuclear Factor 1-alpha; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Metformin; Organic Anion Transport Protein 1; Organic Cation Transport Proteins; Pharmacogenetics; Pharmacogenomic Variants; Polycystic Ovary Syndrome; Time Factors; Treatment Outcome; Triglycerides; Weight Loss; Young Adult | 2018 |
Weight and body composition changes during oral contraceptive use in obese and normal weight women.
Topics: Adult; Body Composition; Body Mass Index; Contraceptives, Oral; Dose-Response Relationship, Drug; Electric Impedance; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Levonorgestrel; Obesity; Outcome Assessment, Health Care; Prospective Studies; Time Factors; Weight Gain; Weight Loss; Young Adult | 2014 |
Comparison of four different treatment regimens on coagulation parameters, hormonal and metabolic changes in women with polycystic ovary syndrome.
Topics: Adult; Blood Coagulation; Cyproterone Acetate; Estrogens; Ethinyl Estradiol; Female; Fibrin Fibrinogen Degradation Products; Hormones; Humans; Hypoglycemic Agents; Insulin Resistance; Lipids; Metformin; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Spironolactone; Weight Loss; Young Adult | 2010 |
Divergent effects of weight reduction and oral anticonception treatment on adrenergic lipolysis regulation in obese women with the polycystic ovary syndrome.
Topics: Adipocytes; Adipose Tissue; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Sequential; Diet, Reducing; Estradiol Congeners; Estrogens; Ethinyl Estradiol; Female; Humans; Lipolysis; Norethindrone; Obesity; Polycystic Ovary Syndrome; Radioligand Assay; Sympathetic Nervous System; Weight Loss | 1999 |
2 other study(ies) available for ethinyl estradiol and Weight Loss
| Article | Year |
|---|---|
The effects of treatment with drospirenone/ethinyl oestradiol alone or in combination with metformin on elastic properties of aorta in women with polycystic ovary syndrome.
Topics: Adolescent; Adult; Androstenes; Aorta; Body Mass Index; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Metformin; Polycystic Ovary Syndrome; Treatment Outcome; Vascular Stiffness; Weight Loss | 2012 |
Impact of subdermal norgestrel on hepatic acyl-coenzyme A:cholesterol- acyltransferase (ACAT) activity: possible antiatherogenic effect.
Topics: Administration, Cutaneous; Animals; Arteriosclerosis; Cholesterol; Ethinyl Estradiol; Female; Liver; Norgestrel; Rats; Rats, Sprague-Dawley; Sterol O-Acyltransferase; Weight Loss | 2000 |